ProfileGDS5678 / 1452082_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 56% 58% 57% 58% 61% 55% 55% 57% 57% 58% 57% 58% 57% 58% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.4761556
GSM967853U87-EV human glioblastoma xenograft - Control 23.4806658
GSM967854U87-EV human glioblastoma xenograft - Control 33.4728257
GSM967855U87-EV human glioblastoma xenograft - Control 43.4327558
GSM967856U87-EV human glioblastoma xenograft - Control 53.5968661
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.4857255
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.4713655
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.4575857
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.4455257
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.4707858
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.4573657
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.4556458
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.4737757
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.4723458